Bruce E. Strober, MD, PhD
Dr. Strober was the Chair of the University of Connecticut Department of Dermatology from 2015 to 2018. He has served as a Section Editor for the British Journal of Dermatology, and is an ad hoc reviewer for Journal of the American Academy of Dermatology, Journal of the American Medical Association (JAMA), JAMA Dermatology, British Journal of Dermatology, and Inflammation. He has published more than 160 book chapters and articles in peer-reviewed journals such as JAMA Dermatology, New England Journal of Medicine, Journal of the American Academy of Dermatology, and Journal of Investigative Dermatology, among others. Dr. Strober also has presented data to the FDA on behalf of multiple pharmaceutical companies, including at the advisory committee for secukinumab, a novel IL-17 inhibitor. His primary clinical focus is the treatment of moderate-to-severe plaque psoriasis and atopic dermatitis.
Dr. Strober earned both his medical degree and his doctorate from Columbia University College of Physicians and Surgeons in New York, New York. He completed his residency in dermatology in the Department of Dermatology, New York University School of Medicine in New York, New York. He is board certified by the American Board of Dermatology and a Fellow in the American Academy of Dermatology.